Clinical Trial Update: Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin

View source ↗

Summary

This document provides an update on an observational safety study evaluating NovoMix in adults with Type 2 diabetes who were previously treated with human premi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Novomix (insulin aspart protamine/insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED